Inventor
DUNCAN KENNETH W
US37 patents
⚠️ This page may combine multiple inventors who share the name “DUNCAN KENNETH W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EPIZYME INC
32 patentsUS9365519B2Jun 14, 2016
PRMT5 inhibitors and uses thereof
EPIZYME INC34 citations98
US8993555B2Mar 31, 2015
PRMT5 inhibitors and uses thereof
EPIZYME INC50 citations98
US8940726B2Jan 27, 2015
PRMT5 inhibitors and uses thereof
EPIZYME INC47 citations98
US8906900B2Dec 9, 2014
PRMT5 inhibitors and uses thereof
EPIZYME INC44 citations98
US9855275B2Jan 2, 2018
Aryl-or heteroaryl-substituted benzene compounds
EPIZYME INC18 citations94
US9718816B2Aug 1, 2017
1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereof
EPIZYME INC25 citations94
US9611257B2Apr 4, 2017
PRMT5 inhibitors and uses thereof
EPIZYME INC22 citations94
US9604930B2Mar 28, 2017
Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
EPIZYME INC21 citations94
US9388173B2Jul 12, 2016
PRMT5 inhibitors and uses thereof
EPIZYME INC32 citations94
US9365555B2Jun 14, 2016
PRMT5 inhibitors and uses thereof
EPIZYME INC37 citations94
US9346761B2May 24, 2016
Arginine methyltransferase inhibitors and uses thereof
EPIZYME INC38 citations94
US9266836B2Feb 23, 2016
PRMT5 inhibitors and uses thereof
EPIZYME INC35 citations94
US9221794B2Dec 29, 2015
PRMT5 inhibitors and uses thereof
EPIZYME INC40 citations94
US9908887B2Mar 6, 2018
PRMT5 inhibitors and uses thereof
EPIZYME INC14 citations93
US9777008B2Oct 3, 2017
PRMT5 inhibitors and uses thereof
EPIZYME INC16 citations93
US9765068B2Sep 19, 2017
PRMT5 inhibitors and uses thereof
EPIZYME INC14 citations93
US9745291B2Aug 29, 2017
PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
EPIZYME INC14 citations93
US9675614B2Jun 13, 2017
PRMT5 inhibitors and uses thereof
EPIZYME INC17 citations93
US10420775B2Sep 24, 2019
Aryl-or heteroaryl-substituted benzene compounds
EPIZYME INC12 citations92
US9732072B2Aug 15, 2017
PRMT5 inhibitors and uses thereof
EPIZYME INC16 citations92
US9732041B2Aug 15, 2017
Arginine methyltransferase inhibitors and uses thereof
EPIZYME INC17 citations92
US11052093B2Jul 6, 2021
Aryl-or heteroaryl-substituted benzene compounds
EPIZYME INC7 citations84
US10391089B2Aug 27, 2019
PRMT5 inhibitors and uses therof
EPIZYME INC5 citations84
US10307413B2Jun 4, 2019
Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
EPIZYME INC5 citations84
US10150758B2Dec 11, 2018
PRMT5 inhibitors and uses thereof
EPIZYME INC9 citations84
US9776972B2Oct 3, 2017
Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
EPIZYME INC14 citations84
US12168016B2Dec 17, 2024
Aryl-OR heteroaryl-substituted benzene compounds
EPIZYME INC0 citations73
US12168015B2Dec 17, 2024
Aryl-or heteroaryl-substituted benzene compounds
EPIZYME INC0 citations73
US12161645B2Dec 10, 2024
Aryl-or heteroaryl-substituted benzene compounds
EPIZYME INC0 citations73
US10980794B2Apr 20, 2021
PRMT5 inhibitors and uses thereof
EPIZYME INC1 citations73
US10118918B2Nov 6, 2018
PRMT5 inhibitors and uses thereof
EPIZYME INC2 citations73
US10653693B2May 19, 2020
PRMT5 inhibitors and uses thereof
EPIZYME INC1 citations59
ACCENT THERAPEUTICS INC
3 patentsUS12391709B2Aug 19, 2025
Inhibitors of KIF18A and uses thereof
ACCENT THERAPEUTICS INC0 citations56
US12233065B2Feb 25, 2025
Inhibitors of RNA helicase DHX9 and uses thereof
ACCENT THERAPEUTICS INC0 citations55
US12162867B2Dec 10, 2024
Inhibitors of RNA helicase DHX9 and uses thereof
ACCENT THERAPEUTICS INC0 citations55